参考文献/References:
[1] TAUBER S C, DJUKIC M, GOSSNER J, et al. Sepsis-associated encephalopathy and septic encephalitis: an update[J]. Expert Rev Anti Infect Ther, 2021, 19(2): 215-231.
[2] Chung HY, WICKEL J, BRUNKHORST FM, et al. Sepsis-associated encephalopathy: from delirium to dementia?[J]. J Clin Med, 2020, 9(3): 703.
[3] KODALI M C, CHEN H, LIAO F F. Temporal unsnarling of brain's acute neuroinflammatory transcriptional profiles reveals panendothelitis as the earliest event preceding microgliosis[J]. Mol Psychiatry, 2021, 26(8): 3905-3919.
[4] GAO Q, HERNANDES M S. Sepsis-associated encephalopathy and blood-brain barrier dysfunction[J]. Inflammation, 2021, 44(6): 2143-2150.
[5] CHEN R, KANG R, Tang D. The mechanism of HMGB1 secretion and release[J]. Exp Mol Med, 2022, 54(2): 91-102.
[6] DEWULF B, MINSART L, VERDONK F, et al. High mobility group box 1(HMGB1): potential target in sepsis-associated encephalopathy[J]. Cells, 2023, 12(7): 1088.
[7] YU T, XIAOJUAN F, JINXI L, et al. Extracellular HMGB1 induced glomerular endothelial cell injury via TLR4/MyD88 signaling pathway in lupus nephritis[J]. Mediators Inflamm, 2021, 2021(12): 9993971.
[8] RITTIRSCH D, HUBER-LANG M S, FLIERL M A, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc, 2009, 4(1): 31-36.
[9] YIN X Y, TANG X H, WANG S X, et al. HMGB1 mediates synaptic loss and cognitive impairment in an animal model of sepsis-associated encephalopathy[J]. J Neuroinflammation, 2023, 20(1): 69.
[10] XIE J, SHEN Z, ANRAKU Y, et al. Nanomaterial-based blood-brain-barrier(BBB)crossing strategies[J]. Biomaterials, 2019, 224(12): 119491.
[11] ABBOTT N J, PATABENDIGE A A, DOLMAN D E, et al. Structure and function of the blood-brain barrier[J]. Neurobiol Dis, 2010, 37(1): 13-25.
[12] LIN L, LI J, SONG Q, et al. The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke-induced inflammation in chronic obstructive pulmonary disease[J]. Immun Inflamm Dis, 2022, 10(11): e711.
[13] ZHANG Y, LIANG X, BAO X, et al. Toll-like receptor 4(TLR4)inhibitors: current research and prospective[J]. Eur J Med Chem, 2022, 235(5): 114291.
[14] ZHU Z, PENG X, LI X, et al. HMGB1 impairs endothelium-dependent relaxation in diabetes through TLR4/ eNOS pathway[J]. FASEB J, 2020, 34(6): 8641-8652.
相似文献/References:
[1]林洁,廖心成,钱彬.和厚朴酚抑制IDO1表达改善老年小鼠术后认知功能障碍的实验研究[J].福建医药杂志,2023,45(06):111.
LIN Jie,LIAO Xincheng,QIAN Bin.Honokiol improves postoperative cognitive dysfunction by inhibiting indoleamine 2,3-dioxygenase 1 in elderly mice[J].FUJIAN MEDICAL JOURNAL,2023,45(06):111.